Biomarkers of Lyme neuroborreliosis: a systematic review
Infection · 2026-10 · 54 (5) · 2317-2332
DOI: 10.1007/s15010-026-02875-y ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Infection, online erschienen am 03.08.2026. Verfasst von Lasse Fjordside und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet Esther Møllers Vej 6, Copenhagen Ø, Denmark, DK-2100. lasse.fjordsi…. Hauptthemen laut MEDLINE: Lyme Neuroborreliosis, Biomarkers. Die Arbeit nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Rigshospitalet, Lundbeck Foundation, Svend Andersen Fonden.
Abstract (Originalsprache)
BACKGROUND: The persistent challenges with diagnosing Lyme neuroborreliosis (LNB) have fostered investigations in a broad spectrum of biomarker candidates. The aim of this systematic review is to provide a comprehensive overview of these potential biomarkers of LNB. METHODS: We conducted a systematic literature review in accordance with PRISMA guidelines on Medline, Embase, Scopus, and Web of Science. The study protocol was published on PROSPERO prior to study-initiation. Studies identified through the combined search strings were screened for eligibility by independent physicians with expertise in LNB. Quality assessment and risk of bias was determined for all included studies using the QUADAS-2 assessment tool. In addition, criteria for consistency and a quality-score were established to quantify and compare diagnostic potential of biomarkers across studies. RESULTS: The search-strings yielded a total of 3113 unique studies of which 74 studies were found eligible for inclusion. The included studies investigated 220 different biomarkers in a total of 2598 patients with LNB from 1990 to 2025 in 13 different countries. No blood-based biomarkers showed consistent diagnostic potential across studies. IL-10 was ranked as the most promising biomarker in CSF. CONCLUSION: The biomarker literature in LNB is characterized by substantial redundancy, with few candidates demonstrating consistent diagnostic potential across studies. Future research should prioritize rigorous validation of the most promising biomarkers rather than continued exploratory investigations to accelerate clinical translation.In addition, improved knowledge of LNB pathogenesis is a requisite for targeted biomarker discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet Esther Møllers Vej 6, Copenhagen Ø, Denmark, DK-2100. lasse.fjordside@regionh.dk.
- Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet Esther Møllers Vej 6, Copenhagen Ø, Denmark, DK-2100.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Lasse Fjordside
Förderung
- Rigshospitalet
- Lundbeck Foundation
- Svend Andersen Fonden
- Danmarks Frie Forskningsfond
Zitieren
APA
Fjordside, L., Florescu, A. M., Dos, A. H., Ørbaek, M., Mens, H., & Lebech, A. M. (2026). Biomarkers of Lyme neuroborreliosis: a systematic review. Infection, 54(5), 2317-2332. https://doi.org/10.1007/s15010-026-02875-y
Vancouver
Fjordside L, Florescu AM, Dos AH, Ørbaek M, Mens H, Lebech AM. Biomarkers of Lyme neuroborreliosis: a systematic review. Infection. 2026;54(5):2317-2332. doi:10.1007/s15010-026-02875-y
BibTeX
@article{Fjordside2026,
author = {Fjordside, Lasse and Florescu, Anna Maria and Dos, Al-Hasan Hussein and Ørbaek, Mathilde and Mens, Helene and Lebech, Anne-Mette},
title = {Biomarkers of Lyme neuroborreliosis: a systematic review},
journal = {Infection},
year = {2026},
volume = {54},
number = {5},
pages = {2317--2332},
doi = {10.1007/s15010-026-02875-y}
}
EUVIMED